228 related articles for article (PubMed ID: 29981275)
1. Canakinumab treatment in kidney transplant recipients with AA amyloidosis due to familial Mediterranean fever.
Trabulus S; Korkmaz M; Kaya E; Seyahi N
Clin Transplant; 2018 Aug; 32(8):e13345. PubMed ID: 29981275
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of Canakinumab Treatment in Recipients of Kidney Transplant With Familial Mediterranean Fever: A Case Series.
Sendogan DO; Saritas H; Kumru G; Eyupoglu S; Sadioglu RE; Tuzuner A; Sengul S; Keven K
Transplant Proc; 2019 Sep; 51(7):2292-2294. PubMed ID: 31400972
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis.
Varan Ö; Kucuk H; Babaoglu H; Guven SC; Ozturk MA; Haznedaroglu S; Goker B; Tufan A
Mod Rheumatol; 2019 Mar; 29(2):363-366. PubMed ID: 29578360
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of interleukin-1 blockers in kidney transplant recipients with familial Mediterranean fever: a propensity score-matched cohort study.
Mirioglu S; Dirim AB; Bektas M; Demir E; Tor YB; Ozluk Y; Kilicaslan I; Oto OA; Yalcinkaya Y; Caliskan Y; Artim-Esen B; Yazici H; Inanc M; Turkmen A; Gul A; Sever MS
Nephrol Dial Transplant; 2023 May; 38(5):1327-1336. PubMed ID: 36542475
[TBL] [Abstract][Full Text] [Related]
5. Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant/unresponsive familial Mediterranean fever.
Şahin A; Derin ME; Albayrak F; Karakaş B; Karagöz Y
Adv Rheumatol; 2020 Jan; 60(1):12. PubMed ID: 32000860
[TBL] [Abstract][Full Text] [Related]
6. Canakinumab treatment in renal transplant recipients with familial Mediterranean fever.
Yildirim T; Yilmaz R; Uzerk Kibar M; Erdem Y
J Nephrol; 2018 Jun; 31(3):453-455. PubMed ID: 29446001
[TBL] [Abstract][Full Text] [Related]
7. Anti-IL-1 treatment in familial Mediterranean fever and related amyloidosis.
Özçakar ZB; Özdel S; Yılmaz S; Kurt-Şükür ED; Ekim M; Yalçınkaya F
Clin Rheumatol; 2016 Feb; 35(2):441-6. PubMed ID: 25213327
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of live donor kidney transplantation for renal amyloidosis.
Sherif AM; Refaie AF; Sobh MA; Mohamed NA; Sheashaa HA; Ghoneim MA
Am J Kidney Dis; 2003 Aug; 42(2):370-5. PubMed ID: 12900821
[TBL] [Abstract][Full Text] [Related]
9. Secondary bladder amyloidosis with familial Mediterranean fever in a living donor kidney transplant recipient: a case report.
Imamura S; Narita S; Nishikomori R; Tsuruta H; Numakura K; Maeno A; Saito M; Inoue T; Tsuchiya N; Nanjo H; Heike T; Satoh S; Habuchi T
BMC Res Notes; 2016 Oct; 9(1):473. PubMed ID: 27760547
[TBL] [Abstract][Full Text] [Related]
10. Canakinumab treatment in children with familial Mediterranean fever: report from a single center.
Yazılıtaş F; Aydoğ Ö; Özlü SG; Çakıcı EK; Güngör T; Eroğlu FK; Gür G; Bülbül M
Rheumatol Int; 2018 May; 38(5):879-885. PubMed ID: 29450637
[TBL] [Abstract][Full Text] [Related]
11. Renal transplantation in patients with familial Mediterranean fever.
Erdem E; Karatas A; Kaya C; Dilek M; Yakupoglu YK; Arık N; Akpolat T
Clin Rheumatol; 2012 Aug; 31(8):1183-6. PubMed ID: 22562368
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of anti-interleukin-1 treatment in 40 patients, followed in a single centre, with AA amyloidosis secondary to familial Mediterranean fever.
Ugurlu S; Ergezen B; Egeli BH; Selvi O; Ozdogan H
Rheumatology (Oxford); 2020 Dec; 59(12):3892-3899. PubMed ID: 32556219
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of kidney transplantation in patients with familial mediterranean fever.
Bitik B; Hatipoğlu B; Sayın B; Kanbur AY; Bursa N; Oygur CŞ; Özdemir H; Colak T; Haberal M; Yücel AE
Clin Transplant; 2023 Feb; 37(2):e14888. PubMed ID: 36544375
[TBL] [Abstract][Full Text] [Related]
14. Amyloid A Amyloidosis After Renal Transplantation: An Important Cause of Mortality.
Sarihan I; Caliskan Y; Mirioglu S; Ozluk Y; Senates B; Seyahi N; Basturk T; Yildiz A; Kilicaslan I; Sever MS
Transplantation; 2020 Aug; 104(8):1703-1711. PubMed ID: 32732850
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of renal transplantation in patients with familial Mediterranean fever amyloidosis: a single-center experience.
Abedi AS; Nakhjavani JM; Etemadi J
Transplant Proc; 2013; 45(10):3502-4. PubMed ID: 24314942
[TBL] [Abstract][Full Text] [Related]
16. Canakinumab in Children with Familial Mediterranean Fever: A Single-Center, Retrospective Analysis.
Kisla Ekinci RM; Balci S; Dogruel D; Altintas DU; Yilmaz M
Paediatr Drugs; 2019 Oct; 21(5):389-395. PubMed ID: 31463794
[TBL] [Abstract][Full Text] [Related]
17. Long-term Results of Kidney Transplantation in Patients With Familial Mediterranean Fever and Amyloidosis.
Sarıtaş H; Sendogan DO; Kumru G; Sadioglu RE; Duman N; Erturk S; Nergisoglu G; Tuzuner A; Sengul S; Keven K
Transplant Proc; 2019 Sep; 51(7):2289-2291. PubMed ID: 31400971
[TBL] [Abstract][Full Text] [Related]
18. Familial Mediterranean fever (FMF) with proteinuria: clinical features, histology, predictors, and prognosis in a cohort of 25 patients.
Kukuy O; Livneh A; Ben-David A; Kopolovic J; Volkov A; Shinar Y; Holtzman E; Dinour D; Ben-Zvi I
J Rheumatol; 2013 Dec; 40(12):2083-7. PubMed ID: 24128782
[TBL] [Abstract][Full Text] [Related]
19. Anti-interleukin-1 treatment in 26 patients with refractory familial mediterranean fever.
Kucuksahin O; Yildizgoren MT; Ilgen U; Ates A; Kinikli G; Turgay M; Erten S
Mod Rheumatol; 2017 Mar; 27(2):350-355. PubMed ID: 27328763
[TBL] [Abstract][Full Text] [Related]
20. Dramatic beneficial effect of interleukin-1 inhibitor treatment in patients with familial Mediterranean fever complicated with amyloidosis and renal failure.
Stankovic Stojanovic K; Delmas Y; Torres PU; Peltier J; Pelle G; Jéru I; Colombat M; Grateau G
Nephrol Dial Transplant; 2012 May; 27(5):1898-901. PubMed ID: 21931121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
